Rozenman Mary M.

CIK 00016489201 companyBRISBANE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001648920

Recent Transactions

50 trades

Tax Payment
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2019-03-01$24.30/sh−626→ 13,878 total
Award
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2019-02-22+7,500→ 14,504 total
Award
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2019-02-22+45,000→ 45,000 total
Award
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-03-04+41,250→ 41,250 total
Award
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-03-04+6,875→ 7,004 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-03-01−1,807→ 105,436 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-03-01$33.10/sh−1,807→ 129 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-03-01$3.02/sh+1,807→ 1,936 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-02-01−6,592→ 107,243 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-02-01$35.58/sh−4,292→ 129 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-02-01$34.95/sh−2,300→ 4,421 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-02-01$3.02/sh+6,592→ 6,721 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-01-02$37.08/sh−1,601→ 129 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-01-02$37.12/sh−4,990→ 1,730 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-01-02−6,591→ 113,835 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-01-02$3.02/sh+6,591→ 6,720 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-26$38.83/sh−8,800→ 11,329 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-26$38.83/sh−11,000→ 39,139 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-26$39.23/sh−1,500→ 25,139 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-26$38.80/sh−4,310→ 20,829 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-26$39.28/sh−1,200→ 10,129 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-26$3.02/sh+75,010→ 75,139 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-26$39.23/sh−1,800→ 50,139 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-26$38.82/sh−10,700→ 51,939 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-26$39.26/sh−700→ 20,129 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-26$38.73/sh−6,400→ 3,729 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-26$38.83/sh−11,000→ 64,139 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-26$39.25/sh−1,500→ 62,639 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-26$39.25/sh−1,500→ 37,639 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-26$38.82/sh−11,000→ 26,639 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-26$39.15/sh−3,600→ 129 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-12-26−75,010→ 120,426 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-09-07−30,000→ 195,436 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-09-07$3.02/sh+30,000→ 30,129 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-09-07$22.50/sh−30,000→ 129 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-07-17−300→ 225,436 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-17$3.02/sh+300→ 429 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-17$21.38/sh−300→ 129 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-14$3.02/sh+5,666→ 5,795 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-07-14−5,666→ 225,736 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-14$21.39/sh−5,666→ 129 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-13$3.02/sh+8,974→ 9,103 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-13$21.47/sh−8,974→ 129 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-07-13−8,974→ 231,402 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-05$21.40/sh−15,060→ 129 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-05$3.02/sh+15,060→ 15,189 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-07-05−15,060→ 225,319 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-03$20.57/sh−30,000→ 129 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-07-03−30,000→ 240,379 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-07-03$3.02/sh+30,000→ 30,129 total

Companies

Aimmune Therapeutics, Inc.
See Remarks

Recent Filings

Address

C/O AIMMUNE THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 300

BRISBANE, CA, 94005-1884

View on SEC.gov